MX2021013899A - Agentes antifungicos para la descolinizacion de candida auris. - Google Patents

Agentes antifungicos para la descolinizacion de candida auris.

Info

Publication number
MX2021013899A
MX2021013899A MX2021013899A MX2021013899A MX2021013899A MX 2021013899 A MX2021013899 A MX 2021013899A MX 2021013899 A MX2021013899 A MX 2021013899A MX 2021013899 A MX2021013899 A MX 2021013899A MX 2021013899 A MX2021013899 A MX 2021013899A
Authority
MX
Mexico
Prior art keywords
candida auris
decolinization
decolonize
fungi
antifungal agents
Prior art date
Application number
MX2021013899A
Other languages
English (en)
Spanish (es)
Inventor
Gonzalez David A Angulo
Stephen Andrew Barat
Original Assignee
Scynexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scynexis Inc filed Critical Scynexis Inc
Publication of MX2021013899A publication Critical patent/MX2021013899A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
MX2021013899A 2019-05-16 2020-05-12 Agentes antifungicos para la descolinizacion de candida auris. MX2021013899A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962849019P 2019-05-16 2019-05-16
PCT/US2020/032547 WO2020232037A1 (en) 2019-05-16 2020-05-12 Antifungal agents, like ibrexafungerp for candida auris decolonization

Publications (1)

Publication Number Publication Date
MX2021013899A true MX2021013899A (es) 2022-02-10

Family

ID=70861571

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021013899A MX2021013899A (es) 2019-05-16 2020-05-12 Agentes antifungicos para la descolinizacion de candida auris.

Country Status (14)

Country Link
US (1) US20220211684A1 (cg-RX-API-DMAC7.html)
EP (1) EP3968986A1 (cg-RX-API-DMAC7.html)
JP (2) JP7770191B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220009416A (cg-RX-API-DMAC7.html)
CN (1) CN113905733A (cg-RX-API-DMAC7.html)
AU (1) AU2020276595B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021022876A2 (cg-RX-API-DMAC7.html)
CA (1) CA3140637A1 (cg-RX-API-DMAC7.html)
EA (1) EA202193146A1 (cg-RX-API-DMAC7.html)
IL (1) IL288165B2 (cg-RX-API-DMAC7.html)
MA (1) MA55958A (cg-RX-API-DMAC7.html)
MX (1) MX2021013899A (cg-RX-API-DMAC7.html)
TW (2) TW202602460A (cg-RX-API-DMAC7.html)
WO (1) WO2020232037A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102980640B1 (ko) 2023-07-03 2026-06-24 연세대학교 산학협력단 칸디다 아우리스에 대한 항진균제 스크리닝 방법 및 항진균용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
ES2402659T3 (es) 2006-04-03 2013-05-07 Merck Sharp & Dohme Corp. Derivados de enfumafungina como agentes antifúngicos
WO2010019204A1 (en) 2008-08-12 2010-02-18 Merck Sharp & Dohme Corp. Antifungal agents
BRPI0912074B1 (pt) * 2008-08-12 2021-08-03 Merck Sharp & Dohme Corp Composto e composição farmacêutica
ES2955711T3 (es) * 2016-03-16 2023-12-05 Cidara Therapeutics Inc Regímenes de dosificación para el tratamiento de infecciones fúngicas
JP7263313B2 (ja) * 2017-04-10 2023-04-24 サイネクシス,インコーポレーテッド 併用される抗真菌剤
WO2018213641A1 (en) * 2017-05-17 2018-11-22 T2 Biosystems, Inc. Nmr methods and systems for the rapid detection of candida species
PL3661503T3 (pl) * 2017-08-04 2023-01-09 Scynexis, Inc. Środki przeciwgrzybicze o zwiększonej aktywności przy kwasowym odczynie ph
MA54866A (fr) * 2019-01-30 2022-05-04 Scynexis Inc Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques

Also Published As

Publication number Publication date
IL288165B1 (en) 2026-01-01
JP7770191B2 (ja) 2025-11-14
EA202193146A1 (ru) 2022-02-11
BR112021022876A2 (pt) 2022-04-12
TWI881977B (zh) 2025-05-01
IL288165A (en) 2022-01-01
WO2020232037A1 (en) 2020-11-19
JP2022532734A (ja) 2022-07-19
CN113905733A (zh) 2022-01-07
MA55958A (fr) 2022-03-23
IL288165B2 (en) 2026-05-01
AU2020276595B2 (en) 2025-12-04
JP2025118765A (ja) 2025-08-13
TW202110441A (zh) 2021-03-16
CA3140637A1 (en) 2020-11-19
AU2020276595A1 (en) 2021-12-09
TW202602460A (zh) 2026-01-16
US20220211684A1 (en) 2022-07-07
EP3968986A1 (en) 2022-03-23
KR20220009416A (ko) 2022-01-24

Similar Documents

Publication Publication Date Title
JOP20220155A1 (ar) مشتقات البيرازول مفيدة كعوامل مضادة للسرطان
SA521422143B1 (ar) 15-pgdh مثبط
WO2020106647A3 (en) Combination therapy including a krasg12c inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
CL2024000067A1 (es) Compuestos antivirales
CR20220456A (es) Derivados de biarilo como inhibidores de la interacción proteína-proteína de yap/taz-tead
CR20220545A (es) ANTICUERPOS MONOCLONALES HUMANOS DIRIGIDOS CONTRA EL CORONAVIRUS 2 DEL SÍNDROME RESPIRATORIO AGUDO GRAVE (SARS-CoV-2)
DOP2024000039A (es) Derivados de quinolina como inhibidores de la integrina alfa4beta7
BR112021007788A8 (pt) Composto inibidor de jak 2-azabiciclo hexano
MX392213B (es) Composiciones farmacéuticas que comprenden sales de glicopirrolato y 1,1-difluoroetano.
MX2023006504A (es) Compuesto de hidroxamato, metodo de preparacion del mismo y aplicacion del mismo.
CL2011000135A1 (es) Uso de una fromulacion farmaceutica acuosa que comprende 0,5-10% de terbinafina o una sal de la misma, 2-10% de un fosfolipido y 1-5% de un surfactante, para preparar un medicamento util para tratar una infeccion fungica; formulacion farmaceutica.
PH12019500849A1 (en) Naphthyridinone derivatives and their use inthe treatment of arrhythmia
MY197561A (en) Composition for increasing expression of pgc-1?
MX2022003845A (es) Tratamientos cognitivos medicinales.
SA522441650B1 (ar) مثبطات فوسفوينوسيتيد 3-كيناز الموضعية
BR112023019657A2 (pt) Antagonista de abhd6
CO2022008616A2 (es) Composición farmacéutica oral que comprende compuesto de carbamato y método de preparación para la misma
CO2024010803A2 (es) Compuestos de tienopirrolotriazina, su preparación y su uso terapéutico
PH12020551341A1 (en) 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof
MX2019014321A (es) Compuestos biciclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias.
EA202193146A1 (ru) Противогрибковые агенты для деколонизации candida auris
BR112021023848A2 (pt) Derivados microbiocidas
MX2023014898A (es) Terapia combinada anti-vhc ventajosa.
BR112022024988A2 (pt) Compostos e métodos para tratamento de infecções fúngicas
MX2022004665A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias.